RU99123233A - METHOD OF TREATING PURULENT RAS WITH SALT SOLUTION BASED ON HIGH-MOLECULAR FRACTION (Navy) WASTE OF DECEMBER PRODUCTION - Google Patents
METHOD OF TREATING PURULENT RAS WITH SALT SOLUTION BASED ON HIGH-MOLECULAR FRACTION (Navy) WASTE OF DECEMBER PRODUCTIONInfo
- Publication number
- RU99123233A RU99123233A RU99123233/14A RU99123233A RU99123233A RU 99123233 A RU99123233 A RU 99123233A RU 99123233/14 A RU99123233/14 A RU 99123233/14A RU 99123233 A RU99123233 A RU 99123233A RU 99123233 A RU99123233 A RU 99123233A
- Authority
- RU
- Russia
- Prior art keywords
- navy
- waste
- solution
- production
- molecular weight
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims 3
- 239000002699 waste material Substances 0.000 title claims 3
- 239000012266 salt solution Substances 0.000 title 1
- 229920002307 Dextran Polymers 0.000 claims 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 3
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims 2
- 230000002421 anti-septic Effects 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 200000000019 wound Diseases 0.000 claims 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims 1
- 239000001110 calcium chloride Substances 0.000 claims 1
- 229910001628 calcium chloride Inorganic materials 0.000 claims 1
- 238000001784 detoxification Methods 0.000 claims 1
- 238000000502 dialysis Methods 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910001629 magnesium chloride Inorganic materials 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001103 potassium chloride Substances 0.000 claims 1
- 235000011164 potassium chloride Nutrition 0.000 claims 1
- 210000004872 soft tissue Anatomy 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
Claims (1)
Поливинилпирролидон с молекулярной массой (8000-12000) ед. - 280-300 г
Калия хлорид - 0,2-0,3 г
Натрия хлорид - 3,0-4,0 г
Кальция хлорид - 0,4-0,5 г
Магния хлорид - 0,2-0,3 г
Высокомолекулярная фракция (ВМФ) - отход декстранового производства с молекулярной массой (30000 220000) ед. и содержанием декстранов 40-60 г/л - Остальное до 1 л
Водородный показатель раствора (pH) - 5,7-6,7
с добавлением перед употреблением в раствор угля активированного из расчета 10 г на 1 л раствора, а также антисептик - хлоргексидина биглюконат в расчете 0,2 г на 1 л раствора или антисептик диоксидин в расчете 5 г па 1 л раствора.A method for the treatment of purulent wounds, including surgery to open the source of purulent infection followed by dialysis and detoxification from purulent foci of soft tissues, characterized in that a method for the treatment of purulent wounds using saline solution based on high molecular weight fraction (Navy a) waste dextran production, having the following composition:
Polyvinylpyrrolidone with a molecular weight of (8000-12000) units. - 280-300 g
Potassium chloride - 0.2-0.3 g
Sodium chloride - 3.0-4.0 g
Calcium chloride - 0.4-0.5 g
Magnesium chloride - 0.2-0.3 g
High molecular weight fraction (Navy) - waste dextran production with a molecular weight (30000 220000) units. and dextran content of 40-60 g / l - the rest is up to 1 l
Hydrogen solution rate (pH) - 5.7-6.7
with the addition of activated carbon at a rate of 10 g per 1 l of the solution, as well as the antiseptic - chlorhexidine digluconate at the rate of 0.2 g per 1 l of the solution or dioxidine antiseptic per 5 g of the pa of 1 l of the solution.
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU99123233A true RU99123233A (en) | 2001-08-10 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kratz et al. | Immobilised heparin accelerates the healing of human wounds in vivo | |
| BR9708468A (en) | Treatment of leukocyte photopheresis. | |
| EP0673262A1 (en) | Wound dressings | |
| ATE113636T1 (en) | COMPOSITION AND METHOD FOR PREVENTING BODY TISSUE ADHESION. | |
| NZ544801A (en) | Antiseptic compositions, methods and systems | |
| EP0976436A4 (en) | Wastewater treating agent, method for wastewater treatment, sludge dehydrant, and method for sludge treatment | |
| ES2070307T3 (en) | A PREPARATION FOR THE TREATMENT OF HYPERTENSION. | |
| ES2125696T3 (en) | USE OF TROPSY CHLORIDE FOR THE PRODUCTION OF A PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF VESIC DYSFUNCTIONS. | |
| DE69834724D1 (en) | Treatment of bowel or bladder infections | |
| AU2544197A (en) | Photopheresis treatment of chronic hcv infections | |
| RU2004124041A (en) | DRUG FOR HEALING OF RAS AND PREVENTION OF ADHESION OF THE BAND OF THE BAND | |
| ATE359798T1 (en) | USE OF DEXTRANSULPHATE TO TREAT IBMIR | |
| EA199900830A1 (en) | THERAPEUTIC MINERALOVITAMIN ASSOCIATION IN THE FORM OF UNITARY LIQUID PREPARATION FOR DRINKING | |
| KR930009612A (en) | Method for preparing virus-free thrombin concentrate | |
| RU99123233A (en) | METHOD OF TREATING PURULENT RAS WITH SALT SOLUTION BASED ON HIGH-MOLECULAR FRACTION (Navy) WASTE OF DECEMBER PRODUCTION | |
| AU3172200A (en) | Use of superabsorbent polymers for treating raw skins, corresponding compositions and methods and resulting treated skins | |
| RU2582220C1 (en) | Wound dressing based on chitosan | |
| ATE249225T1 (en) | AGENT CONTAINING MANNOSE-6-PHOSPHATE AND USE THEREOF IN THE TREATMENT OF FIBROTIC DISEASES | |
| CN114748676B (en) | Chitosan-based efficient hemostatic with Janus structure and preparation method and application thereof | |
| DE60206245D1 (en) | USE OF R-IBUPROFEN METHANESULFONAMIED AND ITS SALTS FOR TREATING AND PREVENTING EXHAUSTION REACTIONS IN TRANSPLATED ORGANS | |
| RU96124444A (en) | BIOLOGICAL COMPOSITION FOR THE TREATMENT OF THE RAS "COLLAHIT" | |
| RU2003113987A (en) | METHOD FOR TREATMENT AND PREVENTION OF DISEASES BY EXPOSURE TO BIOLOGICALLY ACTIVE POINTS AND ZONES | |
| RU99123230A (en) | DIALYSING DISINTOXICATION SOLUTION BASED ON HIGH-MOLECULAR FRACTION (Navy) OF DECTRAN PRODUCTION WASTE FOR TREATMENT OF FUSAL RAS | |
| JP2001017533A (en) | Skin sore covering up and repair material | |
| RU2028158C1 (en) | Composition for wound surface covering |